IMMUNOCORE Trademark

Trademark Overview


On Tuesday, February 3, 2026, a trademark application was filed for IMMUNOCORE with the United States Patent and Trademark Office. The USPTO has given the IMMUNOCORE trademark a serial number of 99631607. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, February 3, 2026. This trademark is owned by Immunocore Limited. The IMMUNOCORE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases, infectious diseases and autoimmune diseases; pharmaceutical preparations, biological preparations and bispecific reagents for use in immunotherapy; diagnostic preparations for medical purposes; diagnostic reagents for medical use

Scientific and technological services, namely, research and design in the field of drug development for the treatment of cancer, infectious diseases and autoimmune diseases; pharmaceutical research and development services; pharmaceutical testing and clinical trials; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services
immunocore

General Information


Serial Number99631607
Word MarkIMMUNOCORE
Filing DateTuesday, February 3, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, February 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases, infectious diseases and autoimmune diseases; pharmaceutical preparations, biological preparations and bispecific reagents for use in immunotherapy; diagnostic preparations for medical purposes; diagnostic reagents for medical use
Indication of Colors claimedThe color(s) blue and light blue is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word IMMUNOCORE in blue and a design consisting of curved, oval shapes arranged in a vertical configuration, with two shapes positioned above two shapes, separated by curved negative space, where the shapes appear in varying shades of blue.
Goods and ServicesScientific and technological services, namely, research and design in the field of drug development for the treatment of cancer, infectious diseases and autoimmune diseases; pharmaceutical research and development services; pharmaceutical testing and clinical trials; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 3, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 3, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunocore Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressOxfordshire OX14 4RY
GB

Trademark Events


Event DateEvent Description
Tuesday, February 3, 2026NEW APPLICATION ENTERED
Tuesday, February 3, 2026APPLICATION FILING RECEIPT MAILED